Doucet, F.* , Fontaine, A.* , Hamaïdia, M.* , Jacques, J.-R.* , Jouant, T.* , Mhaidly, N.* , Qin, S.* , Terres, R.* , Saintmard, X.* , Willems, L.* , & Zwaenepoel, M.*. (12 December 2025). The Complexity of Bovine Leukemia Virus Oncogenesis. Viruses, 17 (12), 1609. doi:10.3390/v17121609 * These authors have contributed equally to this work. |
Joris, T., Jouant, T., Jacques, J.-R., Gouverneur, L., Saintmard, X., Vilanova Mana, L., Jamakhani, M., Reichert, M., & Willems, L. (November 2024). Reduction of antisense transcription affects bovine leukemia virus replication and oncogenesis. PLoS Pathogens, 20 (11), 1012659. doi:10.1371/journal.ppat.1012659 |
Beauvois, A.* , Gazon, H.* , Chauhan, P. S., Jamakhani, M., Jacques, J.-R., Thiry, M., Dejardin, E., Di Valentin, E., Twizere, J.-C., Péloponèse, J.-M., Njock, M.-S., Yasunaga, J.-I., Matsuoka, M., Hamaïdia, M.* , & Willems, L.*. (2023). The helicase-like transcription factor redirects the autophagic flux and restricts human T-cell leukemia virus type 1 infection. Proceedings of the National Academy of Sciences of the United States of America, 120 (31), 2216127120. doi:10.1073/pnas.2216127120 * These authors have contributed equally to this work. |
Hoyos, C.* , Fontaine, A.* , Jacques, J.-R., Heinen, V., Louis, R., Duysinx, B., Scherpereel, A., Wasielewski, E., Jamakhani, M.* , Hamaïdia, M.* , & Willems, L.*. (2022). HDAC Inhibition with Valproate Improves Direct Cytotoxicity of Monocytes against Mesothelioma Tumor Cells. Cancers, 14 (9), 2164. doi:10.3390/cancers14092164 * These authors have contributed equally to this work. |
Suárez Archilla, G., Gutiérrez, G., Camussone, C., Calvinho, L., Abdala, A., Alvarez, I., Petersen, M., Franco, L., Destefano, G., Monti, G., Jacques, J.-R., Joris, T., Willems, L.* , & Trono, K.*. (2022). A safe and effective vaccine against bovine leukemia virus. Frontiers in Immunology, 13, 980514. doi:10.3389/fimmu.2022.980514 * These authors have contributed equally to this work. |
Safari, R., Jacques, J.-R., Brostaux, Y., & Willems, L. (2020). Ablation of non-coding RNAs affects bovine leukemia virus B lymphocyte proliferation and abrogates oncogenesis. PLoS Pathogens, 16. doi:10.1371/journal.ppat.1008502 |
Abdala, A., Alvarez, I., Brossel, H., Calvinho, L., Carignano, H., Franco, L., Gazon, H., Gillissen, C., Hamaïdia, M., Hoyos, C., Jacques, J.-R., Joris, T., Laval, F., Petersen, M., Porquet, F., Porta, N., Ruiz, V., Safari, R., Suárez Archilla, G., ... Willems, L. (2019). BLV: lessons on vaccine development. Retrovirology, 2019 (16), 26. doi:10.1186/s12977-019-0488-8 |
Barez, P.-Y., De Brogniez, A., Carpentier, A., Gazon, H., Gillet, N., Gutiérrez, G., Hamaïdia, M., Jacques, J.-R., Perike, S., Neelature Sriramareddy, S., Renotte, N., Staumont, B., Reichert, M., Trono, K., & Willems, L. (24 November 2015). Recent advances in BLV research. Viruses, 7 (11), 6080-6088. doi:10.3390/v7112929 |
De Brogniez, A., Bouzar, A.-B., Jacques, J.-R., Gillet, N., Pritsh, O., Tomé, L., Reichert, M., & Willems, L. (2014). Hyper-replicative bovine leukemia virus by mutation of an envelope N-linked glycosylation site. Retrovirology, 11 (1), 141. doi:10.1186/1742-4690-11-S1-P141 |